Phase 2 Head and Neck Cancer Trial, Recruiting (NCT03326947)

Phase 2 Head and Neck Cancer Trial, Recruiting NCT03326947 Sponsor: Shanghai Jiao Tong University School of Medicine Condition: Head and Neck Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT03326947 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Head And Neck Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with squamous cell carcinoma (a type of cancer) in your mouth — specifically in the tongue, gums, cheek lining, floor of the mouth, palate, or the area behind the back teeth
You are between 18 and 75 years old
You can be male or female
You are generally well enough to carry out normal daily activities (confirm with trial site)
A lab test on your tumor tissue shows a low level of a specific protein called Stathmin 1
Your cancer is at stage III or IVA (advanced but not yet spread to distant parts of the body)
Your blood cell counts are within an acceptable range — enough white blood cells, hemoglobin, and platelets (confirm with trial site)
Your liver is functioning well enough, based on blood test results
Your kidneys are functioning well enough, based on blood test results
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

Your cancer has spread to other parts of the body, or you have another type of cancer
You have already had surgery on the tumor or nearby lymph nodes (a diagnostic biopsy is the exception)
You have previously had radiotherapy or chemotherapy
You have had another cancer in the past 5 years
You have serious heart or lung conditions
You are not legally able to give consent for yourself
Your kidneys are not filtering well enough (confirm with trial site)
You are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT03326947

Sponsor: Shanghai Jiao Tong University School of Medicine

Phase: Phase 2

Status: Recruiting

Condition: Head and Neck Cancer

More information: https://clinicaltrials.gov/study/NCT03326947

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with squamous cell carcinoma (a type of cancer) in your mouth — specifically in the tongue, gums, cheek lining, floor of the mouth, palate, or the area behind the back teeth
You are between 18 and 75 years old
You can be male or female
You are generally well enough to carry out normal daily activities (confirm with trial site)
A lab test on your tumor tissue shows a low level of a specific protein called Stathmin 1
Your cancer is at stage III or IVA (advanced but not yet spread to distant parts of the body)
Your blood cell counts are within an acceptable range — enough white blood cells, hemoglobin, and platelets (confirm with trial site)
Your liver is functioning well enough, based on blood test results
Your kidneys are functioning well enough, based on blood test results
You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

Your cancer has spread to other parts of the body, or you have another type of cancer
You have already had surgery on the tumor or nearby lymph nodes (a diagnostic biopsy is the exception)
You have previously had radiotherapy or chemotherapy
You have had another cancer in the past 5 years
You have serious heart or lung conditions
You are not legally able to give consent for yourself
Your kidneys are not filtering well enough (confirm with trial site)
You are pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Shanghai Jiao Tong University School of Medicine

Registry

ClinicalTrials.gov

Start date

1 January 2018

Est. completion

1 January 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov